Atara Biotherapeutics Inc Cash Flow-to-Debt Ratio
Atara Biotherapeutics Inc cash flow-to-debt ratio. Atara Biotherapeutics Inc (ATRA) has a Cash Flow-to-Debt Ratio of -0.15x as of September 2025, meaning its operating cash flow of $-9.79 Million could theoretically repay 0% of its total liabilities ($66.80 Million) in one year. Check Atara Biotherapeutics Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Atara Biotherapeutics Inc (2012–2024)
Cash flow-to-debt ratio of Atara Biotherapeutics Inc from 2012 to 2024. Historical debt coverage capacity for Atara Biotherapeutics Inc across 13 annual periods. Check Atara Biotherapeutics Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Atara Biotherapeutics Inc Cash Flow-to-Debt Ratio by Year (2012–2024)
Atara Biotherapeutics Inc cash flow-to-debt ratio by year from 2012 to 2024. Year-by-year debt coverage analysis for Atara Biotherapeutics Inc. For the full cash flow conversion analysis, see Atara Biotherapeutics Inc operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.33x | $-68.72 Million | $206.38 Million | ▲ +54.3% |
| 2023 | -0.73x | $-192.98 Million | $264.74 Million | ▲ +32.7% |
| 2022 | -1.08x | $-270.43 Million | $249.78 Million | ▲ +7.4% |
| 2021 | -1.17x | $-220.52 Million | $188.51 Million | ▲ +18.6% |
| 2020 | -1.44x | $-180.76 Million | $125.78 Million | ▲ +68.2% |
| 2019 | -4.52x | $-235.63 Million | $52.16 Million | ▼ -33.1% |
| 2018 | -3.39x | $-179.77 Million | $52.98 Million | ▼ -54.8% |
| 2017 | -2.19x | $-87.50 Million | $39.91 Million | ▲ +62.8% |
| 2016 | -5.90x | $-60.02 Million | $10.18 Million | ▼ -56.7% |
| 2015 | -3.76x | $-37.16 Million | $9.88 Million | ▲ +33.5% |
| 2014 | -5.66x | $-16.63 Million | $2.94 Million | ▼ -5857.7% |
| 2013 | -0.09x | $-5.97 Million | $62.84 Million | ▲ +69.2% |
| 2012 | -0.31x | $-2.48 Million | $8.02 Million | — |